Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin adjunct to insulin in adults with type 1 diabetes
2015-001709-15Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Sotagliflozin 400 mg + insulin with Placebo + insulin (2 arms). Primary endpoint: Composite glycemic control and safety endpoint at Week 24. Started Jul 2015; status: completed.
02
Drugs
sotagliflozin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-001709-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001709-15.